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Abstract
To analyze the vast number and variety of microorganisms inhabiting the human intestine, emerging
metagenomic technologies are extremely powerful. The intestinal microbes are taxonomically complex
and constitute an ecologically dynamic community (microbiota) that has long been believed to possess
a strong impact on human physiology. Furthermore, they are heavily involved in the maturation and pro-
liferation of human intestinal cells, helping to maintain their homeostasis and can be causative of various
diseases, such as inﬂammatory bowel disease and obesity. A simpliﬁed animal model system has provided
the mechanistic basis for the molecular interactions that occur at the interface between such microbes
and host intestinal epithelia. Through metagenomic analysis, it is now possible to comprehensively
explore the genetic nature of the intestinal microbiome, the mutually interacting system comprising
the host cells and the residing microbial community. The human microbiome project was recently
launched as an international collaborative research effort to further promote this newly developing
ﬁeld and to pave the way to a new frontier of human biology, which will provide new strategies for the
maintenance of human health.
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1. Introduction
An enormous number of microorganisms, the vast
majority of which are bacterial species, are known to
colonize and form complex communities, or micro-
biota, at various sites within the human body. It is
estimated that the human microbiota is composed
of 10
14 bacterial cells, which is 10 times more
than the total number of human cells. The largest
and most complex is the one comprised by intestinal
bacteria that includes as many as 10
12 cells per 1 g of
feces in the average human individual.
1 Thus, within
each human body, intestinal and other microbiota,
along with the ‘host’ human cells, form a complex
ecosystem that, as a whole, interactively performs
various biological processes.
2 Therefore, perhaps we
should regard ourselves as ‘superorganisms’ together
with the indigenous microbes
3 and that the compo-
site genome should be referred to as the human
‘metagenome’.
Studies on human intestinal microbiota should
include microbial ecology and analysis of the complex
metabolism of the microbial community, as well as
various host–microbial interactions occurring at the
interfacebetween microbesand hostintestinal epithe-
lia. Such studies are expected to lead to understanding
of the impact of the microbiota on human health and
disease.
4–6 Along these lines, it should be noted that
an international collaborative project, ‘the human
microbiome project (HMP)’, was launched
7 in 2007
with the aim of collecting and integrating the
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DNA RESEARCH 16, 1–12, (2009) doi:10.1093/dnares/dsn033genomic information from many diverse human
microbiomes (the word ‘microbiome’ was ﬁrst intro-
duced in 2001 to deﬁne the collective genomes of
microbiota
8). This article is intended as an overview
of the recent ﬁndings in relevant research ﬁelds.
2. Microbial diversity of the human
gut microbiota
Over the past decade, the bacterial 16S ribosomal
RNA gene (16S) sequence (1.5 kb) has been a
useful landmark for analyzing the microbial diversity
of human intestinal microbiota. A large-scale 16S
phylotype analysis (grouping only by 16S rRNA
sequence similarity) was carried out for three
human adult microbiota.
9 The analysis of 13 335
bacterial 16S sequences identiﬁed 395 phylotypes
at the strain level using a threshold of 99% sequence
identity (% ID) and a single archaeal phylotype
(Methanobrevibacter smithii) within the three
samples. Members of the genera Bacteroides,
Eubacterium, Clostridium and Ruminococcus were the
major species found in the adult microbiota. Of
the 395 phylotypes, 80% represented sequences
from species yet to be cultivated. This analysis also
indicated high interindividual variations in microbial
composition among the three samples. Another
large-scale 16S analysis estimated 4074 phylotypes
at the species level (97% ID) in 18 348 sequences
obtained from 14 subjects including 12 obese
adults monitored for over 1 year.
10 This and a study
using obese mice together revealed the association
of the intestinal microbiota with obesity.
11 More
recently, 16S analysis was performed for 15 172
sequences from 190 samples including subjects
with inﬂammatory bowel disease (IBD) and healthy
adults.
12 The etiology of IBD is known to largely
correlate with the intestinal microbiota or certain
microbial members.
13–15 These and other studies
demonstrated that the intestinal microbiota of IBD
patients have reduced microbial diversity compared
with those of healthy controls.
12,16 The 16S analysis
of other disease-afﬂicted subjects has also been
performed in epidemiologic studies involving
allergy
17–19 and cancer.
20,21
The analysis of more than 45 000 bacterial 16S
data combined with the three large-scale surveys
described above estimated at least 1800 genera
(90% ID), 16 000 phylotypes at the species level
(97% ID) and 36 000 phylotypes at the strain
level (99% ID) in the human intestinal microbiota,
predicting even greater diversity at the species
level.
12 This analysis also revealed that the majority
(98% of all species) belongs to only four bacterial
divisions: Firmicutes (64%), Bacteroidetes (23%),
Proteobacteria (8%) and Actinobacteria (3%), whereas
other minor taxonomic divisions are quite diverse.
Besides these ‘snapshot’ analyses of the intestinal
microbiota composition, other long-term surveys
have been performed to follow both the overall com-
position and that of limited members over periods
ranging from several months up to 2 years.
10,22–24
These longitudinal studies suggested that the compo-
sition of intestinal microbiota do not drastically
change in adults within the periods examined.
16S analyzes of infant intestinal microbiota have
also been carried out.
25–27 One analysis revealed a
dramatic progression in microbial composition until
at least 1 year after birth with higher interindividual
variations, but less complex than those between
adults, converging toward a proﬁle characteristic to
the adult type at the end of the ﬁrst year of life.
25
As might be expected, fraternal twins tend to show a
signiﬁcantly high similarity in their temporal
microbial composition proﬁles.
25,28 No clear corre-
lation was found in overall microbial composition
due to the mode of delivery (Cesarean section or
vaginal birth) and feeding with breast milk or
formulated milk. Therefore, the source of these early
colonizers is not clear, whereas some speciﬁc species
are known to be transmitted from mother to
baby.
26,29,30 Infant intestinal microbiota is mostly
composed of bacteria such as Staphylococcus,
Streptococcus, Biﬁdobacterium and Enterobacteria.
Both adult and infant intestinal microbiota
members are restricted to a small subset of species
as described above, implying that the intestinal micro-
biota have evolved to shape overall microbial diversity
under strong selective pressures.
4,5
3. Sequence-based metagenomics of the human
gut microbiome
The 16S analysis disclosed the existence of numbers
of unculturable bacteria in the human intestinal
microbiota, with only up to 20% of the 16S data
able to be assigned to known species that have been
successfully cultured in the laboratory during the
past four decades.
9 Purely culturable bacteria are deﬁ-
nitely necessary for comprehensive characterization
of their biological and genetic natures. On the other
hand, it is obvious that the 16S data do not provide
any information on functional features of the
microbial community. Thus, both culture-based and
16S-based approaches have crucial limitations for
further studies, particularly for functional analysis.
Metagenomics, the third and newest approach, has
made it possible to comprehensively explore the
biological nature of these complex communities.
31,32
This culture-independent approach includes shotgun
2 Human Intestinal Microbiome [Vol. 16,sequencing of microbial DNA prepared from the
microbiota containing unculturable species isolated
directly from the environments, followed by intensive
computational analysis of obtained genomic
sequences. Metagenomics is a quite effective and
powerful approach for collecting and analyzing the
information of genes present in the microbial
community, because the proportion of the protein-
coding regions in bacterial genomes can be as high
as 80%, so that most of the metagenomic sequences
obtained contain at least partial gene regions directly
related to functions.
33 Biased data can be minimized
in the metagenomic analysis, but a small fraction of
genes may be relatively under-represented in the
entire data set mainly due to toxicity of the gene pro-
ducts or sequence regions to the host Escherichia coli
during cloning of the microbial DNA.
34 In addition,
the degree of gene coverage is largely dependent on
sequencing depth and complexity of the commu-
nities. These problems can be overcome by employing
next-generation DNA sequencers based on massively
parallel sequencing technologies,
35 by which the
cloning step is eliminated and sequence quantity is
increased by orders-of-magnitude compared with
that of conventional Sanger sequencers.
To date, metagenomic data of human and mouse
intestinal microbiomes have been published from
three separate groups.
11,36,37 Gill et al. obtained
78 megabases (Mb) unique metagenomic sequence
data from the intestinal microbiome of two healthy
human adults. Comparison of gene sets annotated
in the intestinal microbiomes with human genes
identiﬁed signiﬁcant numbers of bacterial genes that
are not encoded in the human genome. The function
of these gene products contributes largely to the
metabolism of glycans, amino acids and xenobiotics,
and biosynthesis of vitamins and isoprenoids, which
are necessary processes in human biology. These ﬁnd-
ings indicate the symbiotic relationship with humans
and support the concept that we are superorganisms,
the union of humans with their microbiota.
3
Kurokawa et al.
37 analyzed 13 human intestinal
microbiomes including adults, children and
unweaned infants and obtained 479 Mb unique
metagenomic sequence data. Unexpectedly, more
than half (up to 90%) of total shotgun reads were
assembled to form unique contigs in each sample,
which is in sharp contrast to soil microbiota in
which ,1% of total reads were assembled. These
results suggest that the amount of sequence data
produced in the two metagenomic studies (around
50 Mb of Sanger sequence data for each sample)
could substantially uncover the major species with
the highest orders of magnitude in quantity in each
microbiota, and that these species may be comprised
of a very limited number of strain-level species,
perhaps accounting for ,20 species in each micro-
biome. The constitution of major species by strain-
level species, not by high species-level diversity,
could be inferred from base-inconsistency in the
generated contigs, with most of those 5 kb display-
ing high sequence similarity of .99.5% ID between
assembled reads. In order to uncover the vast
numbers of other species present at lower orders of
magnitude, it would be necessary to produce
sequence data of several more orders of magnitude.
The analysis by Kurokawa et al. also found 647
novel gene families speciﬁc to these intestinal micro-
biomes when compared with genes present in the
metagenomic data of other microbial communities
such as sea-surface, deep-sea and soil, and signiﬁ-
cantly enriched genes in these microbiomes when
compared with gene sets in known microbes, except
for the gut inhabitants. These gut microbiome-
enriched (gut-enriched) genes were assigned to 237
and 136 clusters of orthologous groups (COGs) for
the adult/child and the infant microbiomes, respect-
ively, sharing 58 COGs between them for a total of
315 COGs in all. In the 315 enriched COGs, the func-
tion related to carbohydrate metabolism was remark-
able in both types, but the functional repertories
clearly differed between the adult and infant types.
The adult type was rich in polysaccharide-degrading
enzymes and the infant type was rich in sugar trans-
porters. These data indicate that the functionality of
healthy intestinal microbiota relies largely on avail-
able nutrients in the diet.
38,39
4. Further analysis of metagenomic genes
identiﬁed in 13 Japanese samples
Genome analysis of several Bacteroides strains domi-
nant in adult intestinal microbiota indicated the rich-
ness of genes involved in polysaccharide
metabolism,
40–42 exemplifying the functional adap-
tation of intestinal microbes to gut habitats rich in
polysaccharides, which are metabolized by bacteria
to generate short-chain fatty acids such as butyrate,
the major energy source for the host.
38 It is also valu-
able to examine and compare the content of genes
belonging to the 315 gut-enriched COGs in each
genome of bacteria isolated from various environ-
ments. Our group recently performed a similarity
search analysis of the enriched genes for 371 bacteria
whose genomic sequences are already available. The
371 bacteria were classiﬁed into seven groups accord-
ing to their origin of isolation. The ratio of adult gut-
enriched genes in each genome is shown in Fig. 1.
The average percentage ratios were 3.9% for all 371
microbes, 9.2% for 46 commensal bacteria, 4.0% for
94 pathogens and 2.7% for 231 bacteria from the
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were 2.8% for all microbes, 6.0% for the commensal
bacteria, 3.5% for the pathogens and 1.9% for the
other bacteria. These data clearly show that most of
the commensal bacteria contain gut-enriched genes
at a higher ratio than the other environmental bac-
teria. Interestingly, many of the commensal bacteria
with lower ratios overlap those of pathogens, implying
that intestinal microbes with a lower ratio of gut-
enriched genes might be primary reservoirs for the
corresponding pathogens. Table 1 lists the top 15
species with a higher ratio of adult and infant gut-
enriched genes, respectively, which differ considerably
from one another, except for the two species,
Ruminococcus and Dorea. For the adult gut-enriched
genes, members aggregated to three species,
Bacteroides, Eubacterium and Ruminococcus, all of
which are known dominant species in adult intestinal
microbiota. For the infant gut-enriched genes,
members are relatively diverse with Clostridium,
Biﬁdobacterium and Lactobacillus species being charac-
teristic. Some of them (e.g. Biﬁdobacterium and
Lactobacillus) are prominent probiotics, living micro-
organisms having beneﬁcial effects on host health.
43
The species with the higher ratios tend to be domi-
nant in intestinal microbiota compared with the
species with the lower ratios. For instance, E. coli
K12 had a ratio of 3.4% for adult gut-enriched
genes, much lower than the 15 species listed, which
is consistent with the minority of E. coli in the adult
intestinal microbiota. It is also possible that the meta-
bolic mutualism between intestinal members may
allow the species with lower ratios, e.g. the human
intestinal archaeon (3.6 and 1.2% for the adult and
the infant gut-enriched genes, respectively), to stably
colonize the gut.
44
In summary, the abundance of speciﬁc gene sets
(i.e. gut-enriched genes) in commensal bacteria
suggests that their genomes have evolved to accumu-
late functions advantageous for competitive survival
and colonization in the gut habitat, a possible conse-
quence of the functional adaptation to the gut ecosys-
tem.
5,42 This distinct feature also suggests the
difﬁculty for these intestinal microbes to survive in
other environments where available nutrients and
surrounding conditions are different in quantity and
quality from those in the gut environment.
Therefore, intestinal microbes may have additional
properties tolerant to transient, but harsh conditions
encountered in the mouth and stomach, through
which they must travel to reach the gut. Genes encod-
ing these yet unidentiﬁed functions may be included
in the 315 gut-enriched COGs that contain many
conserved but function-unknown genes, accounting
for nearly 30% of all gut-enriched COGs, and in the
647 novel gene families identiﬁed.
37
About 75% of the genes annotated in the metage-
nomic sequences of the 13 human intestinal micro-
biomes showed sequence similarity ranging from 40
to 100% ID at the amino acid level with known
Figure 1. Ratio of gut microbiome-enriched genes (adult) in sequenced genomes of bacteria isolated from various environments. The
similarity search was performed with a threshold value of 1e28 for 371 bacteria whose genomic sequences were available from
public databases. The 371 bacteria were classiﬁed into seven groups according to their origin of isolation; commensals, pathogens,
plant-related, soil-born, freshwater-born, seawater-born and others, and shown in red, pink, green, brown, light blue, dark blue and
black dots, respectively.
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37 When, for each gene, the best blastp-hit was
used to tentatively assign the gene to a species, the
distribution of sequence similarity for each species
assigned could be depicted as shown in Fig. 2. Fig. 2
shows two distinct distribution patterns; those that
peaked at high similarity of over 80% ID and those
with low similarity between 50 and 80% ID. Typical
species with the ﬁrst pattern are Escherichia,
Klebsiella, Biﬁdobacterium and Bacteroides, all of
which were previously isolated from humans and
fully sequenced, so it is reasonable that many of the
metagenomic genes showed high sequence similarity
with those in these microbes. On the other hand,
the metagenomic genes showing low similarity with
known genes in tentatively assigned species, such
as Bacillus, Clostridium and Streptococcus, probably
originate from species that are close to the assigned
taxa but have not yet been isolated or sequenced.
These data suggest that human intestinal microbes
constitute distinct phylogenies from those of other
environmental bacteria and have evolved with their
own unique histories including co-evolution with the
human host and its ancestors.
2,5
5. Issues to be considered in 16S
and metagenomic studies
In both cases of 16S rRNA phylotyping and metage-
nomic analysis, establishment of a reliable method for
microbial DNA isolation from any given microbiota is
a critical issue. This is because the intestinal micro-
biota comprise Gram-positive and Gram-negative
bacteria and a small fraction of archaea, some of
which may be hard-to-lyse species. So far, methods
based on mechanical disruption using zirconium/
silica beads
11,22,36,45 and those based on enzymatic
lysis
9,25,37,46,47 have been developed and employed
for the isolation of microbial DNA from various bac-
terial sources.
48–52 The DNA extraction method has
been assessed with respect to the quality and quantity
of obtained DNA as well as fecal sample preser-
vation.
53 Our group recently assessed and compared
the published lysis methods using fecal samples. Our
preliminary results, including UniFrac
54 analysis of
enumerated 16S data, shape and yield of obtained
DNA, showed that many of the methods examined
gave similar results in quality, but varied by more
than 10-fold in quantity and in the degree of DNA
fragmentation (data not shown).
The 16S analysis also has an intrinsic problem in
quantitative evaluation of the microbial composition
because of the existence of multiple heterogeneous
copies of the 16S rRNA genes within a genome
along with uneven PCR-ampliﬁcation of the 16S
region. The range in copy number of the 16S rRNA
gene varies from 1 to as many as 15 in prokaryotic
species.
55 In addition, the PCR primer Bact-8F,
56
often used for ampliﬁcation of the nearly full-length
16S sequence, might not be suitable at least for the
quantiﬁcation of Biﬁdobacteria, of which the 16S
sequence has three base mismatches with the
primer, underscoring the composition of this
species.
25 Recently, an improved primer pool was
developed.
57 Next-generation DNA sequencers guar-
antee the rapid collection of genomic data but
provide less read-length than that of conventional
Sanger sequencers.
35 The feasibility of pyrosequen-
cing reads of 200–300 bases for the 16S phylotype
analysis
58 was evaluated by collecting 141 000
reads from rhesus macaque intestinal microbiota.
59
The results showed high reproducibility of the phylo-
genetic assignments and similarity of the major
types and relative numbers of taxa to those obtained
from Sanger sequences.
Table 1. Top 15 species with the high ratio of adult and infant
gut-enriched genes
Species having higher ratio of
adult gut-enriched genes
Species having higher ratio of
infant gut-enriched genes
Ratio Species Ratio Species
0.152 Bacteroides ovatus 0.102 Biﬁdobacterium longum
NCC2705
0.148 Bacteroides WH2 0.098 Clostridium ramosum
JCM1298
0.144 Bacteroides sp. A01 0.093 Biﬁdobacterium
catenulatum JCM1194
0.143 Bacteroides vulgatus 0.092 Clostridium
clostridioforme
JCM1291
0.141 Bacteroides
thetaiotaomicron 3731
0.087 Collinsella aerofaciens
0.137 Bacteroides
thetaiotaomicron VPI-
5482
0.082 Lactobacillus johnsonii
NCC 533
0.136 Bacteroides
thetaiotaomicron 7330
0.081 Ruminococcus gnavus
0.130 Bacteroides uniformis 0.081 Enterococcus faecalis
V583
0.128 Bacteroides caccae 0.081 Lactobacillus
acidophilus NCFM
0.126 Eubacterium ventriosum 0.079 Dorea longicatena
0.125 Ruminococcus gnavus 0.077 Listeria monocytogenes
EGD-e
0.123 Dorea longicatena 0.076 Lactobacillus plantarum
WCFS1
0.121 Bacteroides sp. A03 0.073 Streptococcus agalactiae
A909
0.121 Ruminococcus torques 0.072 Streptococcus
pneumoniae TIGR4
0.121 Bacteroides fragilis
NCTC 9343
0.072 Streptococcus
pneumoniae R6
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Deciphering biological features of a taxonomically
complex and ecologically dynamic microbial commu-
nity is a challenging issue in gut microbiome research.
Germ-free and gnotobiotic mice,
60 pig
61 and zebra-
ﬁsh
62 provide simpliﬁed model ecosystems that allow
detailedevaluationoffunctionsofcolonizedmicrobiota
or microbes and the corresponding host responses
in vivo,
63,64 as well as their impact on various host
physiologies.
11,65–69 Immunity in germ-free mice is
premature, but is restored by colonization of com-
mensal bacteria and even by a single microbe.
70,71
Protection against pathogenic infection is also a
characteristic feature of commensal bacteria.
72–74
Investigations have been made regarding the func-
tions of commensal bacterial genes on their coloniza-
tion in the mouse intestine. Flexible transcriptional
regulation for adaptation to changes in available
nutrients, including those during weaning, was
found in Bacteroides thetaiotaomicron.
39,75 Surface
glycans expressed by Bacteroides fragilis are essential
for its colonization.
76 The analysis of certain
Lactobacillus strains, which are thought to have
health-promoting properties as probiotics, identiﬁed
genes inducible upon their colonization.
77
Expression proﬁling of both bacterial and host genes
in mono-associated mice colonized by either
Biﬁdobacterium longum or B. thetaiotaomicron and
di-associated mice colonized by both bacteria were
examined.
78 The co-existence of B. longum expanded
diversiﬁcation in the carbohydrate substrates accessed
by B. thetaiotaomicron in a host-independent manner.
On the other hand, the presence of B. longum
signiﬁcantly reduced the expression levels of host
genes responsible for antimicrobial activity against
Gram-positive bacteria compared with that by
B. thetaiotaomicron alone, suggesting the involvement
of host responses in competitive colonization between
these bacteria.
Commensal bacteria share many indistinguishable
features with pathogenic bacteria relating to host
immune response.
79–81 For example, lipopolysac-
charide (LPS), lipoteichoic acid (LTA) and peptidogly-
can, major cell wall components of all bacteria, are
well known ligands recognized by membrane-bound
toll-like receptor 4 (TLR4) and TLR2 (TLR2), that
serve as sensors of bacterial infection and lead to
the production of pro-inﬂammatory cytokines such
as TNFa and IL-6.
82 Commensal bacteria have the
ability to activate pro-inﬂammatory responses
leading to harmful effects on the host via TLR signal-
ing in mice lacking IL-10,
83 an anti-inﬂammatory
cytokine.
84 Commensal bacteria also have the ability
to activate anti-inﬂammatory responses leading to
beneﬁcial effects on the host via TLR signaling when
the cascade to pro-inﬂammatory responses is
lacking.
85 These results indicate that the impact of
intestinal microbiota on the host physiology largely
depends on the state of host immunity and that
host-commensal bacteria interactions are considered
to be placed at the exquisitely equilibrated state
between pro-inﬂammatory and anti-inﬂammatory
responses,
81,86 where the host preserves intestinal
microbes while still being able to sense the bacteria
that penetrate across intestinal borders.
Mammalian epithelia including Paneth and dendric
cells are major sources of endogenous antimicrobial
Figure 2. Distribution of sequence similarity of genes identiﬁed in the human intestinal microbiome. Only the data for the species that had
sufﬁcient numbers of best blastp-hit to known genes were represented. Species names are indicated in the box. Of these, four typical
distribution patterns, which peaked at high sequence similarity (80% ID), are indicated by name in the ﬁgure.
6 Human Intestinal Microbiome [Vol. 16,substances, including: lysozymes, phospholipases and
various antimicrobial peptides such as a-defensins,
87
angiogenin4
88 and RegIIIg.
89 Several studies have
examined the relationships between these antimicro-
bial peptides and their effect on various intestinal
microbes. RegIIIg is a C-type lectin, of which the
expression is mediated by TLR signaling
90 and down-
regulated by a Gram-positive Biﬁdobacterium
strain.
78 The expression of mouse cryptdins, a
counterpart of human a-defensins, requires Nod2
(nucleotide-binding oligomerization domain contain-
ing 2), a cytoplasmic pattern recognition receptor
expressed in Paneth cells that senses for bacterial pep-
tidoglycans.
91,92 Mutations in the Nod2 gene are
highly correlated with the etiological risk of a subset
of Crohn’s disease (CD).
14,93 The expression of a-
defensins at the ileal of patients with CD of the ileal
was signiﬁcantly down-regulated, but not at the ileal
of patients with CD of the colon.
94 Certain
Enterococcus strains have been shown to regulate the
phosphorylation of peroxisome proliferators-activated
receptor g (PPARg) to induce the expression of
downstream target genes including interleukin-10
(IL-10).
95 PPARg-deﬁcient mice exhibited dysfunction
on the maintenance of gut homeostasis.
96 Bacteroides
thetaiotaomicron induced PPARg-mediated cyto-
plasmic re-distribution of the NF-kB subunit RelA in
intestinal cells, selectively attenuating the inﬂamma-
tory response.
97 These ﬁndings indicate that PPARg
is a nuclear factor associated with anti-inﬂammatory
response. The expression of antimicrobial cathelicidin
LL-37 is induced by butyrate, the product of poly-
saccharide fermentation by intestinal microbes.
98
These antimicrobial peptides may suppress microbial
overgrowth and excessive contact of bacteria to
the epithelia by directly killing them, resulting in
minimizing inadequate stimulation of inﬂammatory
responses.
80,99
Some antimicrobial peptides were shown to dra-
matically increase in expression during the post-
natal period.
88,89,99,100 And, it has been shown that
TLR signaling by LPS is activated in vaginally delivered
newborn mice immediately after birth but not in
newborns delivered by Cesarean section.
101,102
These ﬁndings suggest that exposure of maternal-
derived commensals to the intestinal epithelia in neo-
nates is involved in initiating the development of
intestinal homeostasis. Secreted (or mucosal) IgA pro-
duced by gut-associated lymphoid tissues is largely
involved in shaping the intestinal microbiota com-
position, whereas lack of IgA expression can lead to
adaptive immune response.
103–105 Intestinal alkaline
phosphatase (IAP) was found to dephospholyrate the
phosphate moiety in LPS, resulting in detoxiﬁcation
of LPS and prevention of bacterial penetration across
the epithelial barrier, suggesting that IAP plays an
important role in maintenance of gut homeosta-
sis.
106,107 Recently, a study on gene expression of
the TLR4-mediated signaling cascade in LPS-stimu-
lated macrophages identiﬁed two classes of genes:
those responding only to initial LPS stimulation and
those responding to repeated LPS stimulation. The
former class of genes includes pro-inﬂammatory cyto-
kine genes, whereas the latter includes antimicrobial
genes such as cathelicidin-related peptides. Histone
modiﬁcations are involved in this regulation,
108
which could also be linked to disease susceptibility
from environmental factors.
109
In summary, the host has evolved to establish many
processes that sustain unresponsiveness toward the
commensal bacteria while at the same time maintain-
ing responsiveness toward pathogens (Fig. 3). These
processes include the production of IgA, IAP and
various antimicrobial peptides and epigenetic
control of pro-inﬂammatory responses, all of which
sever routes leading to excessive inﬂammatory
response. On the other hand, pathogens also have
evolved to equip various virulence factors, including
effectors, that confer additional abilities for evading
the host defense system, eventually inducing pro-
inﬂammatory responses
79,110 via change of the
microbiota composition in favor of the pathogens.
72
In contrast, commensal bacteria may also have
evolved not only to acquire speciﬁc functions adaptive
to the gut habitat, e.g. carbohydrate metabolism,
energy production, cell maturation and proliferation
toward intestinal homeostasis,
111 but also to elimin-
ate undesired appendages that could result in
sensing for pro-inﬂammatory responses, e.g. profound
depletion of genes for cell motility function in the
metagenomic data of human intestinal micro-
biomes
37 and attenuation of host immune response
by loss of ﬂagellar function.
112
7. HMP and future directions
The HMP aims at a better understanding of the
roles of human microbes on human biology including
their relationship with health and disease.
7 The
project includes metagenomic and 16S analysis of
the microbiota inhabiting various body sites such as
the oral and nasal cavities, the gastrointestinal and
urogenital tracts, and skin in several hundreds of
healthy and disease-afﬂicted subjects, as well as
genome sequencing of nearly 1000 human commen-
sal microbes. In addition, various metadata concern-
ing the host are needed, including variations in host
genotypes
113 and metabolic phenotypes
114 that
largely inﬂuence host–microbe interactions. In this
regards, one challenging issue is the construction of
an integrated metabolic map, of both human and
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115 which will become the new frontier
for medical purposes such as the development of
biomarkers for prediction of disease predisposition
of individuals, extensive drug design targeting the
intestinal microbiota and personalized drug
therapies.
116,117
A simpliﬁed model system using gnotobiotic
animals has provided fundamental knowledge of the
molecular mechanisms involved in intestinal host–
microbe interactions, in which active bacterial com-
ponents have been identiﬁed.
118,119 However, an
enormous number and variety of bacterial com-
ponents and products must participate in these inter-
actions, and most remain unknown. Future studies
will include those to explore and identify intestinal
bacteria and their gene products (including metab-
olites) that are involved in host–microbial inter-
actions, to identify human genes that respond to
Figure 4. Future direction of human intestinal microbiota research. Human intestinal microbiota function is responsible for both human
health and disease in accordance with its own genetic diversity and in association with human genetic variation. The study of human
microbes, especially the vastly abundant intestinal microbes, is a new frontier in human biology. Many questions remain to be answered
about host–microbe interactions, including: what factors and dietary components shape microbiota diversity, which bacteria and their
components interact with host cells, which human genes respond to and how do they react to bacterial signals affecting human
physiology.
Figure 3. Molecular interactions at the frontline between the host, intestinal commensal bacteria and pathogenic bacteria. Commensal
bacteria possess speciﬁc functions adaptive to the gut habitat and are beneﬁcial to host cells, including maintenance of intestinal
homeostasis, but also include functions such as those of TLRs that signal immune responses to pathogenic infection.
81,86 Host cells
produce various antimicrobial substances such as IgA, IAP and antimicrobial peptides at the frontline to suppress excessive immune
response to commensal bacteria, while maintaining responsiveness to pathogens equipped with various virulence factors to evade
the host defense system.
8 Human Intestinal Microbiome [Vol. 16,bacterial signals crucial for human physiology and to
identify dietary components that inﬂuence and
shape the intestinal microbiota composition. These
scientiﬁc challenges will be achieved by using
advanced ‘omics’ technologies coupled with the vast
quantities of genomic data that are already being
accumulated by the HMP. Thus, the human intestinal
microbiome will pave the way leading to a new fron-
tier in human biology, in which the human genome
and the intestinal microbiome are tightly linked
together as an integral part of the ‘human meta-
genome’ (Fig. 4).
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